First American Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

First American Bank's VRTX Position: Q2 2026 in Review

First American Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 2.4% in Q2 2026, selling an estimated $6.65K and leaving 599 shares worth $298K. The position accounts for 0.02% of the portfolio, ranked #193.

First American Bank first reported a position in VRTX in Q2 2023 and has held it in 13 quarters since. The position peaked at $298K in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

• First American Bank held 599 shares of Vertex Pharmaceuticals worth $298K as of Q2 2026.
• First American Bank sold 15 Vertex Pharmaceuticals shares in Q2 2026, an estimated $6.65K.
• Vertex Pharmaceuticals made up 0.02% of First American Bank's portfolio in Q2 2026, its #193 holding.
• First American Bank first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
• First American Bank's Vertex Pharmaceuticals position peaked at $298K in Q1 2025.
• 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.